Case report describes asymptomatic acquired factor V inhibitor in a patient due to levofloxacin and ceftazidime, suggesting pharmacist involvement.
Acquired factor V inhibitor is a rare and clinically challenging condition that can manifest across a spectrum ranging from asymptomatic laboratory abnormalities to life‐threatening hemorrhagic episodes. This case reports a patient with antibiotic‐associated AFVI, who presents asymptomatically and may be managed conservatively with close monitoring and clinical pharmacist guidance.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: